Axogen Valuation
| AXGN Stock | USD 35.21 0.36 1.03% |
At this time, the firm appears to be undervalued. Axogen Inc shows a prevailing Real Value of $37.76 per share. The current price of the firm is $35.21. Our model approximates the value of Axogen Inc from analyzing the firm fundamentals such as Return On Equity of -0.0191, current valuation of 1.74 B, and Profit Margin of (0.01) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Axogen's valuation include:
Price Book 14.1199 | Enterprise Value | Enterprise Value Ebitda 132.2082 | Price Sales 8.1431 | Forward PE 84.7458 |
Undervalued
Today
Please note that Axogen's price fluctuation is very steady at this time. Calculation of the real value of Axogen Inc is based on 3 months time horizon. Increasing Axogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Axogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Axogen Stock. However, Axogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 35.21 | Real 37.76 | Target 37.33 | Hype 35.63 | Naive 36.24 |
The intrinsic value of Axogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Axogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Axogen Inc helps investors to forecast how Axogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Axogen more accurately as focusing exclusively on Axogen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Axogen's intrinsic value based on its ongoing forecasts of Axogen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Axogen's closest peers.
Axogen Cash |
|
Axogen Total Value Analysis
Axogen Inc is presently forecasted to have valuation of 1.74 B with market capitalization of 1.75 B, debt of 68.69 M, and cash on hands of 58.03 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Axogen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.74 B | 1.75 B | 68.69 M | 58.03 M |
Axogen Investor Information
About 87.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.05. Axogen Inc last dividend was issued on the 27th of January 2010. The entity had 105:100 split on the 11th of July 1994. Based on the analysis of Axogen's profitability, liquidity, and operating efficiency, Axogen Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Axogen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Axogen has an asset utilization ratio of 91.95 percent. This suggests that the Company is making $0.92 for each dollar of assets. An increasing asset utilization means that Axogen Inc is more efficient with each dollar of assets it utilizes for everyday operations.Axogen Profitability Analysis
Considering Axogen's profitability and operating efficiency indicators, Axogen Inc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Axogen's ability to earn profits and add value for shareholders.Net Loss | First Reported 1986-09-30 | Previous Quarter 579 K | Current Value 708 K | Quarterly Volatility 3 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.46 | 0.68 |
|
|
For Axogen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Axogen Inc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Axogen utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Axogen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Axogen over time as well as its relative position and ranking within its peers.
Axogen Earnings per Share Projection vs Actual
The next projected EPS of Axogen is estimated to be 0.07 with future projections ranging from a low of 0.01 to a high of 0.1. Axogen's most recent 12-month trailing earnings per share (EPS TTM) is at -0.05. Please be aware that the consensus of earnings estimates for Axogen Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Axogen Earnings Estimation Breakdown
The calculation of Axogen's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Axogen is estimated to be 0.07 with the future projection ranging from a low of 0.01 to a high of 0.1. Please be aware that this consensus of annual earnings estimates for Axogen Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.01 Lowest | Expected EPS | 0.10 Highest |
Axogen Earnings Projection Consensus
Suppose the current estimates of Axogen's value are higher than the current market price of the Axogen stock. In this case, investors may conclude that Axogen is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Axogen's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 9 | 26.59% | 0.0 | 0.07 | -0.05 |
Axogen Ownership Allocation
Axogen holds a total of 50.17 Million outstanding shares. The majority of Axogen Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axogen Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axogen. Please pay attention to any change in the institutional holdings of Axogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Axogen Profitability Analysis
The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 160.52 M.About Axogen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Axogen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Axogen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Axogen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Axogen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Axogen. We calculate exposure to Axogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Axogen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 163.3 M | 171.4 M | |
| Pretax Profit Margin | (0.06) | (0.06) | |
| Operating Profit Margin | (0.02) | (0.02) | |
| Net Loss | (0.06) | (0.06) | |
| Gross Profit Margin | 0.68 | 0.46 |
Axogen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 44.3 M | |
| Forward Price Earnings | 84.7458 |
Axogen Current Valuation Indicators
Axogen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Axogen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Axogen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Axogen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Axogen's worth.When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Health Care Equipment & Supplies sector continue expanding? Could Axogen diversify its offerings? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Axogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth 0.235 | Return On Assets | Return On Equity |
Investors evaluate Axogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Axogen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Axogen's market price to deviate significantly from intrinsic value.
Understanding that Axogen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Axogen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Axogen's market price signifies the transaction level at which participants voluntarily complete trades.